Yayın:
Characteristics and survival results of peritoneal dialysis patients suffering from COVID-19 in Turkey: A multicenter national study

Küçük Resim

Akademik Birimler

Kurum Yazarları

Yazarlar

Gürsu, Meltem
Öztürk, Savaş
Arıcı, Mustafa
Şahin, İdris
Gökçay Bek, Sibel
Yılmaz, Mürvet
Koyuncu, Sümeyra
Karahisar Sıralı, Semahat
Ural, Zeynep
Dursun, Belda

Danışman

Dil

Türü

Yayıncı:

Karger

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Özet

Background: We aimed to study the characteristics of peritoneal dialysis (PD) patients with Coronavirus disease-19 (COVID-19), determine the short-term mortality and other medical complications, and delineate the factors associated with COVID-19 outcome.Methods: In this multicenter national study, we included PD patients with confirmed COVID-19 from 27 centers. The baseline demographic, clinical, laboratory, and radiological data and outcomes at the end of the first month were recorded.Results: We enrolled 142 COVID-19 patients (median age:52 years). 58.2% of patients had mild disease at diagnosis. Lung involvement was detected in 60.8% of patients. 83 (58.4%) patients were hospitalized, 31 (21.8%) patients were admitted to intensive care unit and 24 needed mechanical ventilation. 15 (10.5%) patients were switched to hemodialysis and hemodiafiltration was performed for four (2.8%) patients. Persisting pulmonary symptoms (n=27), lower respiratory system infection (n=12), rehospitalization for any reason (n=24), malnutrition (n=6), hypervolemia (n=13), peritonitis (n=7), ultrafiltration failure (n=7) and in PD modality change (n=8) were reported in survivors. 26 patients (18.31%) died in the first month of diagnosis. The non-survivor group was older, comorbidities were more prevalent. Fever, dyspnea, cough, serious-vital disease at presentation, bilateral pulmonary involvement, and pleural effusion were more frequent among non-survivors. Age (OR:1.102; 95%CI: 1.032-1.117; p: 0.004), moderate-severe clinical disease at presentation (OR:26.825; 95%CI: 4.578-157.172; p<0.001) and baseline CRP (OR:1.008; 95%CI; 1.000-1.016; p:0.040) were associated with first-month mortality in multivariate analysis.Conclusions: Early mortality rate and medical complications are quite high in PD patients with COVID-19. Age, clinical severity of COVID-19, and baseline CRP level are the independent parameters associated with mortality.

Açıklama

Kaynak:

Anahtar Kelimeler:

Konusu

Mortality, Physiology, Urology & nephrology, Cardiovascular system & cardiology

Alıntı

Endorsement

Review

Supplemented By

Referenced By

3

Views

47

Downloads

View PlumX Details